Cargando…
Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106161/ https://www.ncbi.nlm.nih.gov/pubmed/36728931 http://dx.doi.org/10.1097/CM9.0000000000002390 |
_version_ | 1785026367395463168 |
---|---|
author | Huang, He Chen, Min Wu, Wenjuan Yang, Tianhui Liu, Hao Zhu, Zhengwei Wang, Wenjun Yang, Sen Ding, Xian Wang, Hui Sheng, Yujun Zhang, Yaohua Li, Min Zhang, Xuejun |
author_facet | Huang, He Chen, Min Wu, Wenjuan Yang, Tianhui Liu, Hao Zhu, Zhengwei Wang, Wenjun Yang, Sen Ding, Xian Wang, Hui Sheng, Yujun Zhang, Yaohua Li, Min Zhang, Xuejun |
author_sort | Huang, He |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10106161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101061612023-04-17 Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis Huang, He Chen, Min Wu, Wenjuan Yang, Tianhui Liu, Hao Zhu, Zhengwei Wang, Wenjun Yang, Sen Ding, Xian Wang, Hui Sheng, Yujun Zhang, Yaohua Li, Min Zhang, Xuejun Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-02-05 2022-12-24 /pmc/articles/PMC10106161/ /pubmed/36728931 http://dx.doi.org/10.1097/CM9.0000000000002390 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Correspondence Huang, He Chen, Min Wu, Wenjuan Yang, Tianhui Liu, Hao Zhu, Zhengwei Wang, Wenjun Yang, Sen Ding, Xian Wang, Hui Sheng, Yujun Zhang, Yaohua Li, Min Zhang, Xuejun Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis |
title | Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis |
title_full | Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis |
title_fullStr | Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis |
title_full_unstemmed | Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis |
title_short | Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis |
title_sort | efficacy and safety of ixekizumab in chinese patients with plaque psoriasis |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106161/ https://www.ncbi.nlm.nih.gov/pubmed/36728931 http://dx.doi.org/10.1097/CM9.0000000000002390 |
work_keys_str_mv | AT huanghe efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT chenmin efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT wuwenjuan efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT yangtianhui efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT liuhao efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT zhuzhengwei efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT wangwenjun efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT yangsen efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT dingxian efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT wanghui efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT shengyujun efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT zhangyaohua efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT limin efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis AT zhangxuejun efficacyandsafetyofixekizumabinchinesepatientswithplaquepsoriasis |